Published in Antimicrob Agents Chemother on July 30, 2007
Challenges of antibacterial discovery. Clin Microbiol Rev (2011) 3.94
Production of a unique pneumococcal capsule serotype belonging to serogroup 6. Microbiology (2009) 2.07
Genome dynamics in major bacterial pathogens. FEMS Microbiol Rev (2009) 1.06
Regulation of Helicobacter pylori adherence by gene conversion. Mol Microbiol (2012) 0.96
Normal mutation rate variants arise in a Mutator (Mut S) Escherichia coli population. PLoS One (2013) 0.94
Frequent beneficial mutations during single-colony serial transfer of Streptococcus pneumoniae. PLoS Genet (2011) 0.89
Experimental evolution and the dynamics of genomic mutation rate modifiers. Heredity (Edinb) (2014) 0.88
Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains. BMC Genomics (2015) 0.76
Rapid Acquisition of Linezolid Resistance in Methicillin-Resistant Staphylococcus aureus: Role of Hypermutation and Homologous Recombination. PLoS One (2016) 0.75
Molecular Investigation of Quinolone Resistance of Quinolone Resistance-Determining Region in Streptococcus pneumoniae Strains Isolated from Iran Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method. Osong Public Health Res Perspect (2014) 0.75
Mutations of Bacteria from Virus Sensitivity to Virus Resistance. Genetics (1943) 165.64
High mutation frequencies among Escherichia coli and Salmonella pathogens. Science (1996) 10.88
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science (2000) 9.14
The distribution of the numbers of mutants in bacterial populations. J Genet (1949) 8.79
Evolution of high mutation rates in experimental populations of E. coli. Nature (1997) 8.68
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 7.10
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis (2003) 5.21
Determining mutation rates in bacterial populations. Methods (2000) 4.15
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob Agents Chemother (1996) 4.04
Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science (2001) 3.76
Marker discrimination in transformation and mutation of pneumococcus. Proc Natl Acad Sci U S A (1973) 3.68
Proliferation of mutators in A cell population. J Bacteriol (1997) 3.55
The evolution of mutation rates: separating causes from consequences. Bioessays (2000) 3.48
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother (1999) 2.97
Fluctuation tests: how reliable are the estimates of mutation rates? Genetics (1994) 2.11
The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations. Clin Infect Dis (2004) 2.08
Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis (2001) 2.05
High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis (2003) 1.84
Short-sequence tandem and nontandem DNA repeats and endogenous hydrogen peroxide production contribute to genetic instability of Streptococcus pneumoniae. J Bacteriol (2002) 1.69
Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob Agents Chemother (2003) 1.62
Characterization of the mutX gene of Streptococcus pneumoniae as a homologue of Escherichia coli mutT, and tentative definition of a catalytic domain of the dGTP pyrophosphohydrolases. Mol Microbiol (1994) 1.40
Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J Clin Microbiol (2004) 1.25
Heteroduplex DNA mismatch repair system of Streptococcus pneumoniae: cloning and expression of the hexA gene. J Bacteriol (1985) 1.23
Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation. Microb Drug Resist (2003) 1.17
Hyperrecombination in Streptococcus pneumoniae depends on an atypical mutY homologue. J Bacteriol (2000) 1.14
Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clin Infect Dis (2001) 1.13
Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. J Clin Microbiol (2005) 1.10
Spontaneously arising mutL mutators in evolving Escherichia coli populations are the result of changes in repeat length. J Bacteriol (2003) 1.08
Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob Agents Chemother (2003) 1.01
Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother (2006) 0.92
Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations. Antimicrob Agents Chemother (2002) 0.85
Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32
The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol (2008) 5.98
The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis (2010) 5.34
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med (2010) 4.98
Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest (2009) 3.16
The immune response to pneumococcal proteins during experimental human carriage. J Exp Med (2002) 3.03
A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med (2013) 2.70
Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun (2004) 2.53
The impact of emergency department crowding measures on time to antibiotics for patients with community-acquired pneumonia. Ann Emerg Med (2007) 2.51
The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog (2005) 2.41
Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect Immun (2005) 2.32
Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol Microbiol (2006) 2.29
Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults. Clin Infect Dis (2012) 2.24
Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (SpxB) and avoidance of the toxic effects of the fenton reaction. J Bacteriol (2003) 2.20
Access to emergency care in the United States. Ann Emerg Med (2009) 2.19
Availability of rapid human immunodeficiency virus testing in academic emergency departments. Acad Emerg Med (2008) 2.17
Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun (2006) 2.15
Minimization of bacterial size allows for complement evasion and is overcome by the agglutinating effect of antibody. Cell Host Microbe (2011) 2.03
Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine (2011) 2.03
Comparing different measures of retention in outpatient HIV care. AIDS (2012) 1.98
Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway. Mol Microbiol (2004) 1.97
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis (2006) 1.96
Population genetic variation in gene expression is associated with phenotypic variation in Saccharomyces cerevisiae. Genome Biol (2004) 1.96
Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract. Antimicrob Agents Chemother (2005) 1.93
Within-host competition drives selection for the capsule virulence determinant of Streptococcus pneumoniae. Curr Biol (2010) 1.92
Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J Biol Chem (2006) 1.90
The association between emergency department crowding and hospital performance on antibiotic timing for pneumonia and percutaneous intervention for myocardial infarction. Acad Emerg Med (2006) 1.90
Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis (2004) 1.89
Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol (2002) 1.88
Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations. Genetics (2002) 1.85
Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect Immun (2003) 1.83
Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect Immun (2007) 1.83
Antibiotic treatment of acute respiratory infections in acute care settings. Acad Emerg Med (2006) 1.82
The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med (2007) 1.79
Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest (2011) 1.79
The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo. Infect Immun (2006) 1.75
Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med (2002) 1.75
Short-sequence tandem and nontandem DNA repeats and endogenous hydrogen peroxide production contribute to genetic instability of Streptococcus pneumoniae. J Bacteriol (2002) 1.69
Allopatric divergence, secondary contact, and genetic isolation in wild yeast populations. Curr Biol (2007) 1.69
Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc Natl Acad Sci U S A (2005) 1.67
Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun (2011) 1.66
Neutrophil-toxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae. J Immunol (2008) 1.58
beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun (2002) 1.57
Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog (2009) 1.56
Inhibition of the pneumococcal virulence factor StrH and molecular insights into N-glycan recognition and hydrolysis. Structure (2011) 1.53
Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest (2011) 1.53
Changes in veterans' use of outpatient care from 1992 to 2000. Am J Public Health (2005) 1.52
Human neutrophils kill Streptococcus pneumoniae via serine proteases. J Immunol (2009) 1.49
The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J Infect Dis (2002) 1.49
Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA (2012) 1.48
Reduced antibiotic prescribing for acute respiratory infections in adults and children. Br J Gen Pract (2009) 1.46
Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing. PLoS Pathog (2007) 1.45
Complete genetic linkage can subvert natural selection. Proc Natl Acad Sci U S A (2007) 1.42
Microbial communities of the upper respiratory tract and otitis media in children. MBio (2011) 1.38
Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol (2005) 1.36
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clin Infect Dis (2005) 1.35
Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med (2007) 1.35
Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype. Infect Immun (2009) 1.35
Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils. Infect Immun (2010) 1.32
Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med (2002) 1.32
Cigarette smoking among Chinese Americans and the influence of linguistic acculturation. Nicotine Tob Res (2003) 1.27
Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell Microbiol (2007) 1.25
Modifications to the peptidoglycan backbone help bacteria to establish infection. Infect Immun (2010) 1.22
Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A. Antimicrob Agents Chemother (2003) 1.20
Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts. J Acquir Immune Defic Syndr (2014) 1.19
Cancer in light of experimental evolution. Curr Biol (2012) 1.17
Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. Appl Environ Microbiol (2012) 1.17
Unintended consequences of a quality measure for acute bronchitis. Am J Manag Care (2012) 1.16
Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf (2008) 1.15
Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract. J Infect Dis (2004) 1.15
Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae. PLoS Pathog (2011) 1.12
The atypical amino-terminal LPNTG-containing domain of the pneumococcal human IgA1-specific protease is required for proper enzyme localization and function. Mol Microbiol (2006) 1.11
Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. PLoS Pathog (2008) 1.11
Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr Infect Dis J (2011) 1.11
Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe (2011) 1.10
C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm. J Emerg Med (2008) 1.08
Spontaneously arising mutL mutators in evolving Escherichia coli populations are the result of changes in repeat length. J Bacteriol (2003) 1.08
Role of p38 MAP kinase and transforming growth factor-beta signaling in transepithelial migration of invasive bacterial pathogens. J Biol Chem (2007) 1.07
Sympatric natural Saccharomyces cerevisiae and S. paradoxus populations have different thermal growth profiles. FEMS Yeast Res (2004) 1.07
Declining antibiotic prescriptions for upper respiratory infections, 1993-2004. Acad Emerg Med (2007) 1.06
Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol (2008) 1.05
Health insurance coverage for persons in HIV care, 2006-2012. J Acquir Immune Defic Syndr (2014) 1.05
Competition between high- and higher-mutating strains of Escherichia coli. Biol Lett (2011) 1.04
Early bacterial colonization induces toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect Immun (2009) 1.03
Bacteriocin activity of Streptococcus pneumoniae is controlled by the serine protease HtrA via posttranscriptional regulation. J Bacteriol (2008) 1.02
Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia. MBio (2012) 1.02
Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care. Clin Infect Dis (2008) 1.01
Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. J Immunol (2012) 1.01
MARCO is required for TLR2- and Nod2-mediated responses to Streptococcus pneumoniae and clearance of pneumococcal colonization in the murine nasopharynx. J Immunol (2012) 1.01
Antibiotic prescribing for presumed nonbacterial acute respiratory tract infections. Am J Emerg Med (2009) 1.00
Conserved mutations in the pneumococcal bacteriocin transporter gene, blpA, result in a complex population consisting of producers and cheaters. MBio (2011) 1.00
Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae. PLoS Pathog (2012) 0.99